Trial Details
TERMINATEDBasic Information
| Clinical ID | c37 |
|---|---|
| Identifier | NCT03591770 |
| Trial Title | Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Inflammatory Bowel Diseases |
| Interventions | BIOLOGICAL: SHINGRIX |
Participant Information
| Sponsor | Boston Medical Center |
|---|---|
| City | Boston |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2019-07-31 |
|---|---|
| Primary Completion Date | 2024-07-04 |
| Completion Date | 2024-07-04 |